Ameriprise
NVO

Ameriprise’s Novo Nordisk NVO Stock Holding History

Ameriprise’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.9M Buy
1,747,225
+11,049
+0.6% +$524K 0.01% 741
2025
Q4 		$88.7M Buy
1,736,176
+286,665
+20% +$14.7M 0.02% 603
2025
Q3 		$80.3M Sell
1,449,511
-159,969
-10% -$9.36M 0.02% 658
2025
Q2 		$110M Buy
1,609,480
+167,185
+12% +$11.4M 0.03% 518
2025
Q1 		$100M Buy
1,442,295
+123,579
+9% +$10.2M 0.03% 538
2024
Q4 		$113M Buy
1,318,716
+114,228
+9% +$12.4M 0.03% 501
2024
Q3 		$143M Buy
1,204,488
+106,194
+10% +$14.2M 0.04% 428
2024
Q2 		$157M Sell
1,098,294
-2,246
-0.2% -$298K 0.04% 385
2024
Q1 		$141M Buy
1,100,540
+38,302
+4% +$4.56M 0.04% 418
2023
Q4 		$110M Sell
1,062,238
-8,888
-0.8% -$879K 0.03% 488
2023
Q3 		$97.6M Buy
1,071,126
+80,510
+8% +$7.09M 0.03% 505
2023
Q2 		$80.2M Buy
990,616
+95,060
+11% +$7.77M 0.03% 583
2023
Q1 		$71.5M Sell
895,556
-43,956
-5% -$3.12M 0.02% 610
2022
Q4 		$63.7M Sell
939,512
-6,320
-0.7% -$371K 0.02% 636
2022
Q3 		$47.2M Sell
945,832
-222,048
-19% -$11.9M 0.02% 729
2022
Q2 		$65.2M Sell
1,167,880
-474,412
-29% -$26.3M 0.02% 625
2022
Q1 		$91.4M Sell
1,642,292
-20,378
-1% -$1.05M 0.03% 553
2021
Q4 		$93.2M Sell
1,662,670
-42,470
-2% -$2.3M 0.03% 596
2021
Q3 		$82.2M Sell
1,705,140
-217,796
-11% -$10.5M 0.03% 578
2021
Q2 		$80.6M Buy
1,922,936
+63,702
+3% +$2.47M 0.02% 603
2021
Q1 		$62.7M Buy
1,859,234
+22,592
+1% +$805K 0.02% 682
2020
Q4 		$64M Buy
1,836,642
+29,138
+2% +$1.01M 0.02% 635
2020
Q3 		$62.7M Buy
1,807,504
+398,660
+28% +$13.3M 0.03% 565
2020
Q2 		$46.1M Sell
1,408,844
-1,332,088
-49% -$42.5M 0.02% 652
2020
Q1 		$82.5M Sell
2,740,932
-1,062,976
-28% -$31.7M 0.04% 386
2019
Q4 		$110M Sell
3,803,908
-7,592
-0.2% -$210K 0.05% 386
2019
Q3 		$98.5M Sell
3,811,500
-137,898
-3% -$3.49M 0.04% 409
2019
Q2 		$101M Sell
3,949,398
-209,430
-5% -$5.18M 0.05% 421
2019
Q1 		$109M Sell
4,158,828
-334,138
-7% -$8.21M 0.05% 382
2018
Q4 		$104M Buy
4,492,966
+44,858
+1% +$997K 0.05% 359
2018
Q3 		$105M Sell
4,448,108
-267,316
-6% -$6.52M 0.04% 450
2018
Q2 		$109M Buy
4,715,424
+194,614
+4% +$4.63M 0.05% 388
2018
Q1 		$111M Sell
4,520,810
-338,966
-7% -$8.9M 0.05% 353
2017
Q4 		$131M Sell
4,859,776
-266,476
-5% -$6.78M 0.06% 320
2017
Q3 		$124M Sell
5,126,252
-152,344
-3% -$3.44M 0.06% 325
2017
Q2 		$113M Sell
5,278,596
-837,092
-14% -$16.9M 0.06% 323
2017
Q1 		$105M Sell
6,115,688
-3,737,552
-38% -$65.1M 0.05% 339
2016
Q4 		$177M Buy
9,853,240
+1,516,356
+18% +$27.5M 0.1% 220
2016
Q3 		$172M Sell
8,336,884
-13,265,814
-61% -$329M 0.1% 209
2016
Q2 		$581M Sell
21,602,698
-223,606
-1% -$6.13M 0.34% 61
2016
Q1 		$591M Buy
21,826,304
+1,204,152
+6% +$32.3M 0.35% 55
2015
Q4 		$599M Buy
20,622,152
+627,338
+3% +$17.4M 0.35% 61
2015
Q3 		$542M Buy
19,994,814
+3,550,246
+22% +$101M 0.34% 69
2015
Q2 		$450M Buy
16,444,568
+6,398,832
+64% +$180M 0.26% 86
2015
Q1 		$270M Buy
10,045,736
+7,845,902
+357% +$181M 0.15% 138
2014
Q4 		$46.5M Buy
2,199,834
+552,718
+34% +$12.3M 0.03% 543
2014
Q3 		$39.2M Buy
1,647,116
+14,654
+0.9% +$337K 0.02% 605
2014
Q2 		$37.7M Buy
1,632,462
+154,098
+10% +$3.4M 0.02% 671
2014
Q1 		$33.8M Buy
1,478,364
+1,292,864
+697% +$27.5M 0.02% 711
2013
Q4 		$3.43M Sell
185,500
-11,743,630
-98% -$205M ﹤0.01% 2221
2013
Q3 		$202M Sell
11,929,130
-167,140
-1% -$2.81M 0.13% 177
2013
Q2 		$187M Buy
+12,096,270
New +$201M 0.13% 190

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ameriprise's NVO Position: Q1 2026 in Review

Ameriprise increased its Novo Nordisk (NVO) stake by 0.64% in Q1 2026, buying an estimated $524K and bringing the position to 1,747,225 shares worth $63.9M. The position accounts for 0.01% of the portfolio, ranked #741.

Ameriprise first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $599M in Q4 2015. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Ameriprise held 1,747,225 shares of Novo Nordisk worth $63.9M as of Q1 2026.
  • Ameriprise bought 11,049 Novo Nordisk shares in Q1 2026, an estimated $524K.
  • Novo Nordisk made up 0.01% of Ameriprise's portfolio in Q1 2026, its #741 holding.
  • Ameriprise first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Novo Nordisk position peaked at $599M in Q4 2015.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.